S&P Capital Markets ETF SPDR (KCE)

Despite Raymond James’ underperformance compared to other capital market stocks, analysts remain moderately optimistic about its future prospects.

As Charles Schwab has outperformed its industry peers recently, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

MarketAxess has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.

CME Group has significantly outpaced the broader market recently, yet analysts remain cautious about the stock’s prospects.

The Nasdaq has surged ahead of the broader market over the past year, while analysts remain cautiously optimistic about its prospects moving forward.

Over the past year, Morgan Stanley has surpassed the broader market’s performance and analysts are reasonably bullish on its future potential.

MarketAxess Holdings has lagged behind its capital markets industry peers over the past three months, yet analysts maintain a cautiously optimistic outlook on the stock's potential.

Nasdaq has outpaced the broader market over the past year, with analysts maintaining a cautiously optimistic outlook on the stock's future performance.

Despite Morgan’s outperformance relative to the broader S&P 500 Index over the past year, Wall Street analysts maintain a cautiously optimistic outlook about the stock’s prospects.

Charles Schwab underperformed the broader market over the past year, and analysts remain cautiously bullish on the stock’s prospects.